Andrew D. Hamilton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Andrew D. Hamilton has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Sam Thompson
School of Chemistry and the Institute for Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK
24 shared publications - Peter Clarke Knipe
School of Chemistry and Chemical Engineering, Queen's University Belfast, David Keir Building, Belfast, BT9 5AG, UK
10 shared publications - Sunil Kumar
Department of Chemistry and Biochemistry, F. W. Olin Hall, 2190 E. Iliff Ave., University of Denver, Denver, CO 80210, USA
8 shared publications Hannah Lingard
Department of Chemistry
7 shared publicationsIan M. Jones
Chemistry Research Laboratory
7 shared publicationsRichard T. W. Scott
Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA (UK) http://hamilton.chem.ox.ac.uk
6 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (34) , 6992-6998
Water-soluble β-strand peptidomimetics
Non-peptidic β-strand mimetics composed of alternating cyclic ureas and pyridines are conformationally preorganised in aqueous solutions to reproduce the projection of anionic, cationic, and hydrophobic side-chains.
- 2 September 2026
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (34) , 6992-6998
Open AccessWater-soluble β-strand peptidomimetics
Non-peptidic β-strand mimetics composed of alternating cyclic ureas and pyridines are conformationally preorganised in aqueous solutions to reproduce the projection of anionic, cationic, and hydrophobic side-chains.
- Open Access
- 6 November 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-13
O-glycosylated peptides curtail the aggregation and toxicity of human islet amyloid polypeptide
A key pathogenetic pathway of type 2 diabetes (T2D) is pancreatic beta cell failure, losing their capability of producing insulin and regulating blood glucose. Accumulated evidence has demonstrated that the elevated aggregations of human islet amyloid polypeptide (hIAPP), consisting of soluble oligomers and insoluble fibrils, contribute to the beta cell dysfunction and loss. In this work, a focused library of O-glycosylated peptides was designed to target hIAPP monomers. An N-acetylglucosamine modified peptide, SNS, was identified as the most effective inhibitor against hIAPP fibrillation in this library. SNS treatment in beta cells and isolated mouse islets suppressed the hIAPP-induced oxidative stress, cytotoxicity and apoptosis, resulting in beta cell protection and preservation of islet function. Therefore, these results suggest that O-glycosylated strategy will pave a new way for the design of peptide-based antagonists, and shed light on the creation of novel therapeutics for amyloid-related disease.
- 6 November 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-13
Open AccessO-glycosylated peptides curtail the aggregation and toxicity of human islet amyloid polypeptide
A key pathogenetic pathway of type 2 diabetes (T2D) is pancreatic beta cell failure, losing their capability of producing insulin and regulating blood glucose. Accumulated evidence has demonstrated that the elevated aggregations of human islet amyloid polypeptide (hIAPP), consisting of soluble oligomers and insoluble fibrils, contribute to the beta cell dysfunction and loss. In this work, a focused library of O-glycosylated peptides was designed to target hIAPP monomers. An N-acetylglucosamine modified peptide, SNS, was identified as the most effective inhibitor against hIAPP fibrillation in this library. SNS treatment in beta cells and isolated mouse islets suppressed the hIAPP-induced oxidative stress, cytotoxicity and apoptosis, resulting in beta cell protection and preservation of islet function. Therefore, these results suggest that O-glycosylated strategy will pave a new way for the design of peptide-based antagonists, and shed light on the creation of novel therapeutics for amyloid-related disease.
- Open Access
Artificial Intelligence Applied to Non-Invasive Imaging Modalities in Identification of Nonmelanoma Skin Cancer: A Systematic Review
Background: The objective of this study is to systematically analyze the current state of the literature regarding novel artificial intelligence (AI) machine learning models utilized in non-invasive imaging for the early detection of nonmelanoma skin cancers. Furthermore, we aimed to assess their potential clinical relevance by evaluating the accuracy, sensitivity, and specificity of each algorithm and assessing for the risk of bias. Methods: Two reviewers screened the MEDLINE, Cochrane, PubMed, and Embase databases for peer-reviewed studies that focused on AI-based skin cancer classification involving nonmelanoma skin cancers and were published between 2018 and 2023. The search terms included skin neoplasms, nonmelanoma, basal-cell carcinoma, squamous-cell carcinoma, diagnostic techniques and procedures, artificial intelligence, algorithms, computer systems, dermoscopy, reflectance confocal microscopy, and optical coherence tomography. Based on the search results, only studies that directly answered the review objectives were included and the efficacy measures for each were recorded. A QUADAS-2 risk assessment for bias in included studies was then conducted. Results: A total of 44 studies were included in our review; 40 utilizing dermoscopy, 3 using reflectance confocal microscopy (RCM), and 1 for hyperspectral epidermal imaging (HEI). The average accuracy of AI algorithms applied to all imaging modalities combined was 86.80%, with the same average for dermoscopy. Only one of the three studies applying AI to RCM measured accuracy, with a result of 87%. Accuracy was not measured in regard to AI based HEI interpretation. Conclusion: AI algorithms exhibited an overall favorable performance in the diagnosis of nonmelanoma skin cancer via noninvasive imaging techniques. Ultimately, further research is needed to isolate pooled diagnostic accuracy for nonmelanoma skin cancers as many testing datasets also include melanoma and other pigmented lesions.
Open AccessArtificial Intelligence Applied to Non-Invasive Imaging Modalities in Identification of Nonmelanoma Skin Cancer: A Systematic Review
Background: The objective of this study is to systematically analyze the current state of the literature regarding novel artificial intelligence (AI) machine learning models utilized in non-invasive imaging for the early detection of nonmelanoma skin cancers. Furthermore, we aimed to assess their potential clinical relevance by evaluating the accuracy, sensitivity, and specificity of each algorithm and assessing for the risk of bias. Methods: Two reviewers screened the MEDLINE, Cochrane, PubMed, and Embase databases for peer-reviewed studies that focused on AI-based skin cancer classification involving nonmelanoma skin cancers and were published between 2018 and 2023. The search terms included skin neoplasms, nonmelanoma, basal-cell carcinoma, squamous-cell carcinoma, diagnostic techniques and procedures, artificial intelligence, algorithms, computer systems, dermoscopy, reflectance confocal microscopy, and optical coherence tomography. Based on the search results, only studies that directly answered the review objectives were included and the efficacy measures for each were recorded. A QUADAS-2 risk assessment for bias in included studies was then conducted. Results: A total of 44 studies were included in our review; 40 utilizing dermoscopy, 3 using reflectance confocal microscopy (RCM), and 1 for hyperspectral epidermal imaging (HEI). The average accuracy of AI algorithms applied to all imaging modalities combined was 86.80%, with the same average for dermoscopy. Only one of the three studies applying AI to RCM measured accuracy, with a result of 87%. Accuracy was not measured in regard to AI based HEI interpretation. Conclusion: AI algorithms exhibited an overall favorable performance in the diagnosis of nonmelanoma skin cancer via noninvasive imaging techniques. Ultimately, further research is needed to isolate pooled diagnostic accuracy for nonmelanoma skin cancers as many testing datasets also include melanoma and other pigmented lesions.
- Open Access
- 4 July 2022
- Published by Elsevier in Preventive Medicine Reports
- Vol. 28, 101893
The interface between U.S. primary care clinics and pharmacies for HPV vaccination delivery: A scoping literature review
- 4 July 2022
- Published by Elsevier in Preventive Medicine Reports
- Vol. 28, 101893
Open AccessThe interface between U.S. primary care clinics and pharmacies for HPV vaccination delivery: A scoping literature review
- Open Access
- 30 March 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (33) , 5132-5135
Rationally designed helical peptidomimetics disrupt α-synuclein fibrillation
Misfolding of the human protein α-synuclein results in toxic fibrils, which are a hallmark of Parkinson's disease. Herein we show that structure-guided rationally designed peptidomimetics drastically slow the rate of protein aggregation.
- 30 March 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 58 (33) , 5132-5135
Open AccessRationally designed helical peptidomimetics disrupt α-synuclein fibrillation
Misfolding of the human protein α-synuclein results in toxic fibrils, which are a hallmark of Parkinson's disease. Herein we show that structure-guided rationally designed peptidomimetics drastically slow the rate of protein aggregation.
- 20 August 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (73) , 9192-9195
The helical supramolecular assembly of oligopyridylamide foldamers in aqueous media can be guided by adenosine diphosphates
A metal-free and achiral tri-pyridylamide foldamer, DM 11, containing a critical naphthalimide side chain self-assembles in a left-handed helical manner in the presence of chiral adenosine phosphates, under physiological conditions. Surprisingly, a very high degree of helicity in the foldamer assemblies was observed with ADP compared to other nucleoside phosphates, including ATP.
- 20 August 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (73) , 9192-9195
The helical supramolecular assembly of oligopyridylamide foldamers in aqueous media can be guided by adenosine diphosphates
A metal-free and achiral tri-pyridylamide foldamer, DM 11, containing a critical naphthalimide side chain self-assembles in a left-handed helical manner in the presence of chiral adenosine phosphates, under physiological conditions. Surprisingly, a very high degree of helicity in the foldamer assemblies was observed with ADP compared to other nucleoside phosphates, including ATP.
- 3 July 2021
- Published by Taylor & Francis in Medical Reference Services Quarterly
- Vol. 40 (3) , 337-346
Evolving Librarian Engagement in Undergraduate Medical Education Student Research and Scholarship
Undergraduate Medical Education (UME) program curriculum redesign at Oregon Health & Science University (OHSU) in the early 2010s resulted in incorporation of a long-term research project—called “Scholarly Projects”—into the UME experience. Since 2014, OHSU librarians have participated in curricular support for Scholarly Projects, focusing on helping students develop skills in searching and information management at a moment when the students are starting their projects. This library participation has developed over time and continues to change in response to ongoing librarian reflection on student engagement with the material.
- 3 July 2021
- Published by Taylor & Francis in Medical Reference Services Quarterly
- Vol. 40 (3) , 337-346
Evolving Librarian Engagement in Undergraduate Medical Education Student Research and Scholarship
Undergraduate Medical Education (UME) program curriculum redesign at Oregon Health & Science University (OHSU) in the early 2010s resulted in incorporation of a long-term research project—called “Scholarly Projects”—into the UME experience. Since 2014, OHSU librarians have participated in curricular support for Scholarly Projects, focusing on helping students develop skills in searching and information management at a moment when the students are starting their projects. This library participation has developed over time and continues to change in response to ongoing librarian reflection on student engagement with the material.
- Open Access
- 25 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-24
Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
Missense mutations in p53 are severely deleterious and occur in over 50% of all human cancers. The majority of these mutations are located in the inherently unstable DNA-binding domain (DBD), many of which destabilize the domain further and expose its aggregation-prone hydrophobic core, prompting self-assembly of mutant p53 into inactive cytosolic amyloid-like aggregates. Screening an oligopyridylamide library, previously shown to inhibit amyloid formation associated with Alzheimer’s disease and type II diabetes, identified a tripyridylamide, ADH-6, that abrogates self-assembly of the aggregation-nucleating subdomain of mutant p53 DBD. Moreover, ADH-6 targets and dissociates mutant p53 aggregates in human cancer cells, which restores p53’s transcriptional activity, leading to cell cycle arrest and apoptosis. Notably, ADH-6 treatment effectively shrinks xenografts harboring mutant p53, while exhibiting no toxicity to healthy tissue, thereby substantially prolonging survival. This study demonstrates the successful application of a bona fide small-molecule amyloid inhibitor as a potent anticancer agent.
- 25 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-24
Open AccessProtein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function
Missense mutations in p53 are severely deleterious and occur in over 50% of all human cancers. The majority of these mutations are located in the inherently unstable DNA-binding domain (DBD), many of which destabilize the domain further and expose its aggregation-prone hydrophobic core, prompting self-assembly of mutant p53 into inactive cytosolic amyloid-like aggregates. Screening an oligopyridylamide library, previously shown to inhibit amyloid formation associated with Alzheimer’s disease and type II diabetes, identified a tripyridylamide, ADH-6, that abrogates self-assembly of the aggregation-nucleating subdomain of mutant p53 DBD. Moreover, ADH-6 targets and dissociates mutant p53 aggregates in human cancer cells, which restores p53’s transcriptional activity, leading to cell cycle arrest and apoptosis. Notably, ADH-6 treatment effectively shrinks xenografts harboring mutant p53, while exhibiting no toxicity to healthy tissue, thereby substantially prolonging survival. This study demonstrates the successful application of a bona fide small-molecule amyloid inhibitor as a potent anticancer agent.
- Open Access
- 19 August 2020
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 1 (4) , 225-232
Sub-stoichiometric inhibition of IAPP aggregation: a peptidomimetic approach to anti-amyloid agents
Membrane-catalysed misfolding of islet amyloid polypeptide is associated with the death of β-cells in type II diabetes (T2D). Most active compounds so far reported require high doses for inhibition of membrane bound IAPP fibrillation. Here, we describe a naphthalimide-appended oligopyridylamide-based α-helical mimetic, DM 1, for targeting membrane bound IAPP. DM 1 completely inhibits the aggregation of IAPP at doses of 0.2 equivalents. DM 1 is also effective at similarly low doses for inhibition of seed-catalyzed secondary nucleation. An NMR based study demonstrates that DM 1 modulates IAPP self-assembly by stabilizing and/or perturbing the N-terminus helix conformation. DM 1 at substoichiometric doses rescues rat insulinoma cells from IAPP-mediated cytotoxicity. Most importantly, 0.2 equivalents of DM 1 disaggregate preformed oligomers and fibrils and can reverse cytotoxicity by modulating toxic preformed oligomers and fibrils of IAPP into non-toxic conformations.
- 19 August 2020
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 1 (4) , 225-232
Open AccessSub-stoichiometric inhibition of IAPP aggregation: a peptidomimetic approach to anti-amyloid agents
Membrane-catalysed misfolding of islet amyloid polypeptide is associated with the death of β-cells in type II diabetes (T2D). Most active compounds so far reported require high doses for inhibition of membrane bound IAPP fibrillation. Here, we describe a naphthalimide-appended oligopyridylamide-based α-helical mimetic, DM 1, for targeting membrane bound IAPP. DM 1 completely inhibits the aggregation of IAPP at doses of 0.2 equivalents. DM 1 is also effective at similarly low doses for inhibition of seed-catalyzed secondary nucleation. An NMR based study demonstrates that DM 1 modulates IAPP self-assembly by stabilizing and/or perturbing the N-terminus helix conformation. DM 1 at substoichiometric doses rescues rat insulinoma cells from IAPP-mediated cytotoxicity. Most importantly, 0.2 equivalents of DM 1 disaggregate preformed oligomers and fibrils and can reverse cytotoxicity by modulating toxic preformed oligomers and fibrils of IAPP into non-toxic conformations.